{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T02:24:03Z","timestamp":1794191043607,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10637-026-01634-y","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:01:49Z","timestamp":1787914909000},"page":"429-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Qishen Yiqi Dripping Pills ameliorate doxorubicin-induced cardiotoxicity: a study based on bioinformatics and experimental verification"],"prefix":"10.1007","volume":"44","author":[{"given":"Jiangtao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"10","key":"1634_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrcardio.2010.121","volume":"7","author":"MS Ewer","year":"2010","unstructured":"Ewer MS, Ewer SM (2010) Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat Rev Cardiol 7(10):564\u2013575","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"1634_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/cells12040659","volume":"12","author":"M Kciuk","year":"2023","unstructured":"Kciuk M, Gielecinska A, Mujwar S et al (2023) Doxorubicin-an agent with multiple mechanisms of anticancer activity. Cells 12(4):659","journal-title":"Cells"},{"key":"1634_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4938287","author":"Z Ping","year":"2023","unstructured":"Ping Z, Fangfang T, Yuliang Z et al (2023) Oxidative stress and pyroptosis in doxorubicin-induced heart failure and atrial fibrillation. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2023\/4938287","journal-title":"Oxid Med Cell Longev"},{"issue":"1\u20133","key":"1634_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/ars.2021.0002","volume":"37","author":"R Tan","year":"2022","unstructured":"Tan R, Cong T, Xu G et al (2022) Anthracycline-induced atrial structural and electrical remodeling characterizes early cardiotoxicity and contributes to atrial conductive instability and dysfunction. Antioxid Redox Signal 37(1\u20133):19\u201339","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"1634_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/jaoacint\/qsaa130","volume":"104","author":"Q Xie","year":"2021","unstructured":"Xie Q, Gong L, Huang F et al (2021) A rapid and accurate 1HNMR method for the identification and quantification of major constituents in Qishen Yiqi Dripping Pills. J AOAC Int 104(2):506\u2013514","journal-title":"J AOAC Int"},{"key":"1634_CR6","doi-asserted-by":"publisher","first-page":"1271608","DOI":"10.3389\/fcvm.2023.1271608","volume":"10","author":"X Wang","year":"2023","unstructured":"Wang X, Dai G, Guan H et al (2023) Clinical efficacy and safety of adjunctive treatment of chronic ischemic heart failure with Qishen Yiqi dropping pills: a systematic review and meta-analysis. Front Cardiovasc Med 10:1271608","journal-title":"Front Cardiovasc Med"},{"key":"1634_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.626375","volume":"11","author":"M Wang","year":"2020","unstructured":"Wang M, Shan Y, Wu C et al (2020) Efficacy and safety of Qishen Yiqi Dripping Pill for heart failure with preserved ejection fraction: a systematic review and meta-analysis. Front Pharmacol 11:626375","journal-title":"Front Pharmacol"},{"key":"1634_CR8","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.2147\/IJGM.S436999","volume":"16","author":"X He","year":"2023","unstructured":"He X, Jiang Y, Li S et al (2023) Efficacy and safety of QiShen YiQi dripping pills in the treatment of coronary heart disease complicating chronic heart failure (syndrome of Qi deficiency with blood stasis): study protocol for a randomized, placebo-controlled, double-blind and multi-centre phase II clinical trial. Int J Gen Med 16:6177\u20136188","journal-title":"Int J Gen Med"},{"issue":"7","key":"1634_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11655-019-3154-z","volume":"26","author":"PD Liao","year":"2020","unstructured":"Liao PD, Chen KJ, Ge JB, Zhang MZ (2020) Clinical practice guideline of integrative Chinese and Western medicine for acute myocardial infarction. Chin J Integr Med 26(7):539\u2013551","journal-title":"Chin J Integr Med"},{"issue":"9","key":"1634_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11655-022-3288-2","volume":"29","author":"CM Lu","year":"2023","unstructured":"Lu CM, Yang YS, Lu YM et al (2023) Qishen Yiqi dripping pills for cardiovascular diseases: effects and mechanisms. Chin J Integr Med 29(9):857\u2013864","journal-title":"Chin J Integr Med"},{"key":"1634_CR11","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.12659\/MSM.915194","volume":"25","author":"L Wang","year":"2019","unstructured":"Wang L, Wang L, Zhou X, Ruan G, Yang G (2019) Qishen yiqi dropping pills ameliorates doxorubicin-induced cardiotoxicity in mice via enhancement of cardiac angiogenesis. Med Sci Monit 25:2435\u20132444","journal-title":"Med Sci Monit"},{"issue":"1","key":"1634_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12935-023-02936-4","volume":"23","author":"M Singh","year":"2023","unstructured":"Singh M, Kadhim MM, Turki JA et al (2023) A systematic review of the protective effects of silymarin\/silibinin against doxorubicin-induced cardiotoxicity. Cancer Cell Int 23(1):88","journal-title":"Cancer Cell Int"},{"issue":"6","key":"1634_CR13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52(6):1213\u20131225","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"1634_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15743-0","volume":"12","author":"M Zhou","year":"2022","unstructured":"Zhou M, Sun X, Wang C, Wang F, Fang C, Hu Z (2022) PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis. Sci Rep 12(1):11684","journal-title":"Sci Rep"},{"key":"1634_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110630","volume":"122","author":"H Hua","year":"2023","unstructured":"Hua H, Zhao Q, Xia J et al (2023) Peficitinib ameliorates doxorubicin-induced cardiotoxicity by suppressing cellular senescence and enhances its antitumor activity. Int Immunopharmacol 122:110630","journal-title":"Int Immunopharmacol"},{"key":"1634_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155473","volume":"127","author":"W Li","year":"2024","unstructured":"Li W, Cao J, Zhang Y et al (2024) Aucubin alleviates doxorubicin-induced cardiotoxicity through crosstalk between NRF2 and HIPK2 mediating autophagy and apoptosis. Phytomedicine 127:155473","journal-title":"Phytomedicine"},{"issue":"Pt A","key":"1634_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109274","volume":"113","author":"Y Yin","year":"2022","unstructured":"Yin Y, Niu Q, Hou H et al (2022) PAE ameliorates doxorubicin-induced cardiotoxicity via suppressing NHE1 phosphorylation and stimulating PI3K\/AKT phosphorylation. Int Immunopharmacol 113(Pt A):109274","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"1634_CR18","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.3390\/molecules28114305","volume":"28","author":"RA Syahputra","year":"2023","unstructured":"Syahputra RA, Harahap U, Harahap Y et al (2023) Vernonia amygdalina ethanol extract protects against doxorubicin-induced cardiotoxicity via TGFbeta, cytochrome c, and apoptosis. Molecules 28(11):4305","journal-title":"Molecules"},{"key":"1634_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/497314","author":"S Zheng","year":"2015","unstructured":"Zheng S, Zhang Y, Qiao Y (2015) The mechanism research of Qishen Yiqi formula by module-network analysis. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2015\/497314","journal-title":"Evid Based Complement Alternat Med"},{"issue":"7","key":"1634_CR20","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1073\/pnas.1320243111","volume":"111","author":"GO Ahn","year":"2014","unstructured":"Ahn GO, Seita J, Hong BJ et al (2014) Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8. Proc Natl Acad Sci U S A 111(7):2698\u20132703","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1634_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117113","volume":"178","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang S, Wang Y et al (2024) The natural compound sinometumine E derived from Corydalis decumbens promotes angiogenesis by regulating HIF-1\/ VEGF pathway in vivo and in vitro. Biomed Pharmacother 178:117113","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1634_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cbin.12126","volume":"48","author":"X Zhou","year":"2024","unstructured":"Zhou X, Xia Q, Chen M et al (2024) THBS1 promotes angiogenesis and accelerates ESCC malignant progression by the HIF-1\/VEGF signaling pathway. Cell Biol Int 48(3):311\u2013324","journal-title":"Cell Biol Int"},{"key":"1634_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110654","volume":"385","author":"H Liu","year":"2023","unstructured":"Liu H, Yao Z, Sun M et al (2023) Inhibition of AKR1Cs by liquiritigenin and the structural basis. Chem Biol Interact 385:110654","journal-title":"Chem Biol Interact"},{"issue":"2","key":"1634_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113008","volume":"411","author":"Z Xu","year":"2022","unstructured":"Xu Z, Hu Z, Xu H et al (2022) Liquiritigenin alleviates doxorubicin-induced chronic heart failure via promoting ARHGAP18 and suppressing RhoA\/ROCK1 pathway. Exp Cell Res 411(2):113008","journal-title":"Exp Cell Res"},{"key":"1634_CR25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2147\/IJN.S235832","volume":"15","author":"C Shi","year":"2020","unstructured":"Shi C, Wu H, Xu K et al (2020) Liquiritigenin-loaded submicron emulsion protects against doxorubicin-induced cardiotoxicity via antioxidant, anti-inflammatory, and anti-apoptotic activity. Int J Nanomedicine 15:1101\u20131115","journal-title":"Int J Nanomedicine"},{"key":"1634_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.fitote.2015.09.018","volume":"106","author":"G D'Andrea","year":"2015","unstructured":"D\u2019Andrea G (2015) Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia 106:256\u2013271","journal-title":"Fitoterapia"},{"key":"1634_CR27","doi-asserted-by":"crossref","unstructured":"Lovegrove JA, Stainer A, Hobbs DA (2017) Role of flavonoids and nitrates in cardiovascular health. Proc Nutr Soc 76(2):83\u201395","DOI":"10.1017\/S0029665116002871"},{"key":"1634_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104629","volume":"152","author":"T Hussain","year":"2020","unstructured":"Hussain T, Tan B, Murtaza G et al (2020) Flavonoids and type 2 diabetes: evidence of efficacy in clinical and animal studies and delivery strategies to enhance their therapeutic efficacy. Pharmacol Res 152:104629","journal-title":"Pharmacol Res"},{"key":"1634_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.semcancer.2019.07.023","volume":"69","author":"H Khan","year":"2021","unstructured":"Khan H, Ullah H, Martorell M et al (2021) Flavonoids nanoparticles in cancer: treatment, prevention and clinical prospects. Semin Cancer Biol 69:200\u2013211","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"1634_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071920","volume":"15","author":"H Dorostkar","year":"2023","unstructured":"Dorostkar H, Haghiralsadat BF, Hemati M et al (2023) Reduction of doxorubicin-induced cardiotoxicity by co-administration of smart liposomal doxorubicin and free quercetin: in vitro and in vivo studies. Pharmaceutics 15(7):1920","journal-title":"Pharmaceutics"},{"issue":"1","key":"1634_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ptr.7342","volume":"36","author":"P Zhang","year":"2022","unstructured":"Zhang P, Zhang J, Zhao L, Li S, Li K (2022) Quercetin attenuates the cardiotoxicity of doxorubicin-cyclophosphamide regimen and potentiates its chemotherapeutic effect against triple-negative breast cancer. Phytother Res 36(1):551\u2013561","journal-title":"Phytother Res"},{"issue":"19","key":"1634_CR32","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1111\/bph.12795","volume":"171","author":"Q Dong","year":"2014","unstructured":"Dong Q, Chen L, Lu Q et al (2014) Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression. Br J Pharmacol 171(19):4440\u20134454","journal-title":"Br J Pharmacol"},{"key":"1634_CR33","volume":"2014","author":"D Wang","year":"2014","unstructured":"Wang D, Lu J, Liu Y et al (2014) Liquiritigenin induces tumor cell death through mitogen-activated protein kinase- (MPAKs-) mediated pathway in hepatocellular carcinoma cells. Biomed Res Int 2014:965316","journal-title":"Biomed Res Int"},{"issue":"9","key":"1634_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20024","volume":"9","author":"W Shen","year":"2023","unstructured":"Shen W, Liu Q, Li C et al (2023) Exploration of the effect and potential mechanism of quercetin in repairing spinal cord injury based on network pharmacology and in vivo experimental verification. Heliyon 9(9):e20024","journal-title":"Heliyon"},{"key":"1634_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2023.108440","volume":"120","author":"A Sadeghi","year":"2023","unstructured":"Sadeghi A, Khazaeel K, Tabandeh MR, Nejaddehbashi F, Givi ME (2023) Prenatal exposure to crude oil vapor reduces differentiation potential of rat fetal mesenchymal stem cells by regulating ERK1\/2 and PI3K signaling pathways: protective effect of quercetin. Reprod Toxicol 120:108440","journal-title":"Reprod Toxicol"},{"issue":"1","key":"1634_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3892\/mmr.2014.2734","volume":"11","author":"FY Chen","year":"2015","unstructured":"Chen FY, Cao LF, Wan HX et al (2015) Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase\/extracellular signal-regulated kinase\/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells. Mol Med Rep 11(1):341\u2013348","journal-title":"Mol Med Rep"},{"key":"1634_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155989","volume":"134","author":"G Shu","year":"2024","unstructured":"Shu G, Chen K, Li J et al (2024) Galangin alleviated doxorubicin-induced cardiotoxicity by inhibiting ferroptosis through GSTP1\/JNK pathway. Phytomedicine 134:155989","journal-title":"Phytomedicine"},{"issue":"9","key":"1634_CR38","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/s41401-020-0364-z","volume":"41","author":"YH Hu","year":"2020","unstructured":"Hu YH, Liu J, Lu J et al (2020) sFRP1 protects H9c2 cardiac myoblasts from doxorubicin-induced apoptosis by inhibiting the Wnt\/PCP-JNK pathway. Acta Pharmacol Sin 41(9):1150\u20131157","journal-title":"Acta Pharmacol Sin"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-026-01634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-026-01634-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-026-01634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T02:08:54Z","timestamp":1794190134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-026-01634-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1634"],"URL":"https:\/\/doi.org\/10.1007\/s10637-026-01634-y","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the Animal Ethics Committee of Xinjiang Medical University (IACUC-20250305\u2013238), and all experiments were performed in accordance with relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Patient and public involvement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}